speb/financial-data huggingface dataset:
Financial ratios for CHTR — annual report dated 2024-12-31
Total revenue: 55085000000
Gross profit: 30736000000
Operating income: 13245000000
Net income: 5853000000
Capital expenditures: 11269000000
Operating cash flow: 14430000000
Depreciation & amortization: 8673000000
Net tangible assets: -82524000000
Owner earnings: 3257000000
Return on net tangible assets (%): -3.9467306480539
Capex to operating income (%): 85.08116270290675
Buffett classification: The Gruesome
Stock price: 342.77
P/E ratio: 6.985263272311635
Shares outstanding: 119277492
Book value: 19707000000
P/B ratio: 2.0746306354513626
Market cap (USD): 40884745932.84
Debt to equity: 4.859339321053433
Current ratio: 0.3138810618419101
Quick ratio: 0.3138810618419101
Effective tax rate (%): 21.98080511863503
Interest coverage ratio: 2.5329890992541597
COGS to revenue (%): 44.202595988018516
SG&A to revenue (%): 7.699010619950984
Free cash flow (dilution-adjusted): 2510000000
Buyback yield (%): 2.966876697711549
Retained earnings: -7750000000
Receivables turnover: 17.786567646109138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.700880366795083
FCF margin (%): 4.556594354179904
Revenue growth (%): 0.875345651656381
Rule of 40 score: 5.431940005836284
Financial ratios for CHTR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 342.77
Shares outstanding: 119277492
Market cap (USD): 40884745932.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHTR — quarterly report dated 2025-03-31
Total revenue: 13735000000
Gross profit: 7795000000
Operating income: 3360000000
Net income: 1409000000
Capital expenditures: 2399000000
Operating cash flow: 4236000000
Depreciation & amortization: 2181000000
Net tangible assets: -81713000000
Owner earnings: 1191000000
Return on net tangible assets (%): -1.457540415845704
Capex to operating income (%): 71.39880952380952
Buffett classification: The Good
Stock price: 368.53
P/E ratio: 7.79938504733144
Shares outstanding: 119277492
Book value: 20522000000
P/B ratio: 2.1419615109034202
Market cap (USD): 43957334126.759995
Debt to equity: 4.656320046779066
Current ratio: 0.3633703920421299
Quick ratio: 0.3633703920421299
Effective tax rate (%): 24.002157497303127
Interest coverage ratio: 2.7074939564867044
COGS to revenue (%): 43.24717874044412
SG&A to revenue (%): 8.525664361121223
Free cash flow (dilution-adjusted): 1342000000
Buyback yield (%): 1.8244964485045165
Retained earnings: -6533000000
Receivables turnover: 4.148293566898218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.447516790256552
FCF margin (%): 9.770658900618857
Rule of 40 score: 9.770658900618857
Financial ratios for CHTR — quarterly report dated 2025-06-30
Total revenue: 13766000000
Gross profit: 7777000000
Operating income: 3360000000
Net income: 1495000000
Capital expenditures: 2601000000
Operating cash flow: 3600000000
Depreciation & amortization: 2176000000
Net tangible assets: -81605000000
Owner earnings: 1070000000
Return on net tangible assets (%): -1.3111941670240794
Capex to operating income (%): 77.41071428571429
Buffett classification: The Gruesome
Stock price: 408.81
P/E ratio: 16.791264292190082
Shares outstanding: 119277492
Book value: 20368000000
P/B ratio: 2.3940412168362135
Market cap (USD): 48761831504.52
Debt to equity: 4.7271700706991355
Current ratio: 0.3305853256389118
Quick ratio: 0.3305853256389118
Effective tax rate (%): 21.686746987951807
Interest coverage ratio: 2.660332541567696
COGS to revenue (%): 43.505738776696205
SG&A to revenue (%): 8.099665843382246
Free cash flow (dilution-adjusted): 842000000
Buyback yield (%): 2.9756880642711274
Retained earnings: -5232000000
Receivables turnover: 3.8788391096083403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.451964125429641
FCF margin (%): 6.11651895975592
Revenue growth (%): 0.22570076447033124
Rule of 40 score: 6.3422197242262515
Financial ratios for CHTR — quarterly report dated 2025-09-30
Total revenue: 13672000000
Gross profit: 7669000000
Operating income: 3250000000
Net income: 1316000000
Capital expenditures: 3051000000
Operating cash flow: 4480000000
Depreciation & amortization: 2160000000
Net tangible assets: -82393000000
Owner earnings: 425000000
Return on net tangible assets (%): -0.5158205187333875
Capex to operating income (%): 93.87692307692308
Buffett classification: The Gruesome
Stock price: 275.11
P/E ratio: 7.775931474909953
Shares outstanding: 119277492
Book value: 19588000000
P/B ratio: 1.6752313061119053
Market cap (USD): 32814430824.120003
Debt to equity: 4.955329793751276
Current ratio: 0.3745574880714176
Quick ratio: 0.3745574880714176
Effective tax rate (%): 24.106113033448672
Interest coverage ratio: 2.5630914826498423
COGS to revenue (%): 43.9072557050907
SG&A to revenue (%): 8.243124634289059
Free cash flow (dilution-adjusted): 1278000000
Buyback yield (%): 6.439240135918661
Retained earnings: -4095000000
Receivables turnover: 3.799888827126181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.323818785036037
FCF margin (%): 9.347571679344647
Revenue growth (%): -0.6828417841057678
Rule of 40 score: 8.664729895238878
Financial ratios for CHTR — annual report dated 2025-12-31
Total revenue: 54774000000
Gross profit: 30968000000
Operating income: 13324000000
Net income: 5766000000
Capital expenditures: 11659000000
Operating cash flow: 16077000000
Depreciation & amortization: 8711000000
Net tangible assets: -81567000000
Owner earnings: 2818000000
Return on net tangible assets (%): -3.454828545858006
Capex to operating income (%): 87.50375262683878
Buffett classification: The Gruesome
Stock price: 208.75
P/E ratio: 4.318275486472425
Shares outstanding: 119277492
Book value: 20519000000
P/B ratio: 1.2134692945562648
Market cap (USD): 24899176455
Debt to equity: 4.733222866611433
Current ratio: 0.38659251465504285
Quick ratio: 0.38659251465504285
Effective tax rate (%): 22.687047465808526
Interest coverage ratio: 2.64260214200714
COGS to revenue (%): 43.462226603863144
SG&A to revenue (%): 8.133420966151823
Free cash flow (dilution-adjusted): 3745000000
Buyback yield (%): 20.61112346135225
Retained earnings: -5393000000
Receivables turnover: 14.884239130434782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.455882248575302
FCF margin (%): 6.837185525979479
Revenue growth (%): -0.5645820096214941
Rule of 40 score: 6.272603516357985
Financial ratios for CHTR — quarterly report dated 2025-12-31
Total revenue: 13601000000
Gross profit: 7749000000
Operating income: 3354000000
Net income: 1546000000
Capital expenditures: 3335000000
Operating cash flow: 3761000000
Depreciation & amortization: 2194000000
Net tangible assets: -81567000000
Owner earnings: 405000000
Return on net tangible assets (%): -0.49652432969215493
Capex to operating income (%): 99.43351222420989
Buffett classification: The Gruesome
Stock price: 208.75
P/E ratio: 4.318275486472425
Shares outstanding: 119277492
Book value: 20519000000
P/B ratio: 1.2134692945562648
Market cap (USD): 24899176455
Debt to equity: 4.733222866611433
Current ratio: 0.38659251465504285
Quick ratio: 0.38659251465504285
Effective tax rate (%): 21.162672106068335
Interest coverage ratio: 2.6409448818897636
COGS to revenue (%): 43.02624806999486
SG&A to revenue (%): 7.661201382251305
Free cash flow (dilution-adjusted): 283000000
Buyback yield (%): 3.07640697026419
Retained earnings: -5393000000
Receivables turnover: 3.6959239130434782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.380293384998616
FCF margin (%): 2.0807293581354314
Revenue growth (%): -0.5193095377413692
Rule of 40 score: 1.5614198203940621
Financial ratios for COO — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 104.19
Shares outstanding: 195030630
Market cap (USD): 20320241339.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COO — annual report dated 2022-10-31
Total revenue: 3308400000
Gross profit: 2139600000
Operating income: 507600000
Net income: 385800000
Capital expenditures: 242000000
Operating cash flow: 692400000
Depreciation & amortization: 346100000
Net tangible assets: 1679700000
Owner earnings: 489900000
Return on net tangible assets (%): 29.16592248615824
Capex to operating income (%): 47.67533490937746
Buffett classification: The Good
Stock price: 68.34
P/E ratio: 34.54741641835148
Shares outstanding: 195030630
Book value: 7174700000
P/B ratio: 1.8576934581515605
Market cap (USD): 13328393254.2
Debt to equity: 0.38515896135030037
Current ratio: 1.1979378222152788
Quick ratio: 0.7068426808311201
Effective tax rate (%): 18.830212497370084
Interest coverage ratio: 8.858638743455497
COGS to revenue (%): 35.32825535001813
R&D to revenue (%): 3.333937855156571
SG&A to revenue (%): 40.56945955749002
Free cash flow (dilution-adjusted): 396200000
Buyback yield (%): 0.5889682162196357
Retained earnings: 6584900000
Inventory turnover: 1.8590742802608557
Receivables turnover: 5.931158121190391
Capitalized R&D asset: 110300000
ROCI (R&D-adjusted, %): 5.629827688651218
FCF margin (%): 11.975577318341193
Rule of 40 score: 11.975577318341193
Financial ratios for COO — annual report dated 2023-10-31
Total revenue: 3593200000
Gross profit: 2357900000
Operating income: 533100000
Net income: 294200000
Capital expenditures: 392500000
Operating cash flow: 607500000
Depreciation & amortization: 367700000
Net tangible assets: 2216000000
Owner earnings: 269400000
Return on net tangible assets (%): 12.157039711191336
Capex to operating income (%): 73.62596135809416
Buffett classification: The Good
Stock price: 77.94
P/E ratio: 51.6678698239293
Shares outstanding: 195030630
Book value: 7551000000
P/B ratio: 2.0130694348033376
Market cap (USD): 15200687302.199999
Debt to equity: 0.3402463249900675
Current ratio: 1.7594427244582043
Quick ratio: 1.00030959752322
Effective tax rate (%): 28.747880842819086
Interest coverage ratio: 5.062678062678063
COGS to revenue (%): 34.37882667260381
R&D to revenue (%): 3.823889569186241
SG&A to revenue (%): 41.77891572971168
Free cash flow (dilution-adjusted): 152900000
Buyback yield (%): 0
Retained earnings: 6876100000
Inventory turnover: 1.6793094072865689
Receivables turnover: 5.893390191897654
Capitalized R&D asset: 211301000
ROCI (R&D-adjusted, %): 5.3932895406050525
Rosenberg metric: 1.9791477787851315
FCF margin (%): 4.255259935433597
Revenue growth (%): 8.608390762906541
Rule of 40 score: 12.863650698340138
Financial ratios for COO — annual report dated 2024-10-31
Total revenue: 3895400000
Gross profit: 2595700000
Operating income: 705700000
Net income: 392300000
Capital expenditures: 421200000
Operating cash flow: 709300000
Depreciation & amortization: 375100000
Net tangible assets: 2454000000
Owner earnings: 346200000
Return on net tangible assets (%): 14.10757946210269
Capex to operating income (%): 59.68541873317273
Buffett classification: The Good
Stock price: 104.68
P/E ratio: 52.0413111098649
Shares outstanding: 195030630
Book value: 8083600000
P/B ratio: 2.5255834465337226
Market cap (USD): 20415806348.4
Debt to equity: 0.3196224454450987
Current ratio: 1.9079976535001955
Quick ratio: 1.1231912397340633
Effective tax rate (%): 32.62922891980079
Interest coverage ratio: 6.1741032370953635
COGS to revenue (%): 33.364994609026034
R&D to revenue (%): 3.9816193458951585
SG&A to revenue (%): 39.372079889099965
Free cash flow (dilution-adjusted): 213000000
Buyback yield (%): 0
Retained earnings: 7268400000
Inventory turnover: 1.619160333873178
Receivables turnover: 5.432914923291492
Capitalized R&D asset: 283557000
ROCI (R&D-adjusted, %): 6.276226953273352
Rosenberg metric: 1.7307132459970889
FCF margin (%): 5.467987883144222
Revenue growth (%): 8.410330624512968
Rule of 40 score: 13.87831850765719
Financial ratios for COO — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 104.68
Shares outstanding: 195030630
Market cap (USD): 20415806348.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COO — quarterly report dated 2025-01-31
Total revenue: 964700000
Gross profit: 660200000
Operating income: 182000000
Net income: 104300000
Capital expenditures: 89400000
Operating cash flow: 190600000
Depreciation & amortization: 91000000
Net tangible assets: 2595800000
Owner earnings: 105900000
Return on net tangible assets (%): 4.07966715463441
Capex to operating income (%): 49.12087912087912
Buffett classification: The Good
Stock price: 96.55
P/E ratio: 45.13472513542665
Shares outstanding: 195030630
Book value: 8127500000
P/B ratio: 2.3168511013841893
Market cap (USD): 18830207326.5
Debt to equity: 0.3125069209474008
Current ratio: 1.9877951180472189
Quick ratio: 1.1445578231292517
Effective tax rate (%): 31.963470319634702
Interest coverage ratio: 7
COGS to revenue (%): 31.564216854980824
R&D to revenue (%): 4.218928164196123
SG&A to revenue (%): 40.20939152068001
Free cash flow (dilution-adjusted): 101200000
Buyback yield (%): 0
Retained earnings: 7372700000
Inventory turnover: 0.36125281765333966
Receivables turnover: 1.3465940815187047
Capitalized R&D asset: 40700000
ROCI (R&D-adjusted, %): 1.8567678507483008
FCF margin (%): 10.490307867730902
Rule of 40 score: 10.490307867730902
Financial ratios for COO — quarterly report dated 2025-04-30
Total revenue: 1002300000
Gross profit: 679100000
Operating income: 184800000
Net income: 87700000
Capital expenditures: 78100000
Operating cash flow: 96200000
Depreciation & amortization: 92600000
Net tangible assets: 2729200000
Owner earnings: 102200000
Return on net tangible assets (%): 3.7446870877912946
Capex to operating income (%): 42.26190476190476
Buffett classification: The Good
Stock price: 81.67
P/E ratio: 45.40522107212087
Shares outstanding: 195030630
Book value: 8288100000
P/B ratio: 1.921809769681833
Market cap (USD): 15928151552.1
Debt to equity: 0.31194121692547144
Current ratio: 2.099456790123457
Quick ratio: 1.2300246913580246
Effective tax rate (%): 39.307958477508656
Interest coverage ratio: 7.636363636363637
COGS to revenue (%): 32.24583458046493
R&D to revenue (%): 4.539559014267185
SG&A to revenue (%): 39.808440586650704
Free cash flow (dilution-adjusted): 18100000
Buyback yield (%): 0.2548946113878933
Retained earnings: 7460400000
Inventory turnover: 0.3671475633306827
Receivables turnover: 1.2835190165194006
Capitalized R&D asset: 72769000
ROCI (R&D-adjusted, %): 1.756745407034599
Rosenberg metric: 0.4643734643734644
FCF margin (%): 1.8058465529282648
Revenue growth (%): 3.8975847413703737
Rule of 40 score: 5.703431294298639
Financial ratios for COO — quarterly report dated 2025-07-31
Total revenue: 1060300000
Gross profit: 692000000
Operating income: 175700000
Net income: 98300000
Capital expenditures: 96900000
Operating cash flow: 261400000
Depreciation & amortization: 95400000
Net tangible assets: 2855100000
Owner earnings: 96800000
Return on net tangible assets (%): 3.3904241532695876
Capex to operating income (%): 55.150825270347184
Buffett classification: The Good
Stock price: 70.69
P/E ratio: 47.49126846262487
Shares outstanding: 195030630
Book value: 8353000000
P/B ratio: 1.6505106230934994
Market cap (USD): 13786715234.699999
Debt to equity: 0.2966957979169161
Current ratio: 2.1164241164241164
Quick ratio: 1.2442332442332442
Effective tax rate (%): 35.286372613561554
Interest coverage ratio: 6.917322834645669
COGS to revenue (%): 34.735452230500805
R&D to revenue (%): 4.206356691502405
SG&A to revenue (%): 39.77176270866736
Free cash flow (dilution-adjusted): 164500000
Buyback yield (%): 0.3822520383053865
Retained earnings: 7558700000
Inventory turnover: 0.4180476730987514
Receivables turnover: 1.3382557112204974
Capitalized R&D asset: 88516000
ROCI (R&D-adjusted, %): 1.542542214325896
Rosenberg metric: 0.2835164835164835
FCF margin (%): 15.514477034801471
Revenue growth (%): 5.786690611593335
Rule of 40 score: 21.301167646394806
Financial ratios for COO — quarterly report dated 2025-10-31
Total revenue: 1065100000
Gross profit: 650800000
Operating income: 140400000
Net income: 84600000
Capital expenditures: 98000000
Operating cash flow: 247900000
Depreciation & amortization: 98400000
Net tangible assets: 2799200000
Owner earnings: 85000000
Return on net tangible assets (%): 3.0365818805372964
Capex to operating income (%): 69.8005698005698
Buffett classification: The Good
Stock price: 69.91
P/E ratio: 36.36860854441184
Shares outstanding: 195030630
Book value: 8239100000
P/B ratio: 1.6548641651758078
Market cap (USD): 13634591343.3
Debt to equity: 0.3040744741537304
Current ratio: 1.892882818116463
Quick ratio: 1.1326383896477354
Effective tax rate (%): 27.56849315068493
Interest coverage ratio: 5.754098360655738
COGS to revenue (%): 38.89775607924138
R&D to revenue (%): 3.8869589709886396
SG&A to revenue (%): 39.35780677870622
Free cash flow (dilution-adjusted): 149900000
Buyback yield (%): 1.4433875944269279
Retained earnings: 7643300000
Inventory turnover: 0.4897163120567376
Receivables turnover: 1.284800965018094
Capitalized R&D asset: 86297000
ROCI (R&D-adjusted, %): 1.2136089219578503
Rosenberg metric: -0.9237668161434978
FCF margin (%): 14.073795887710075
Revenue growth (%): 0.45270206545317365
Rule of 40 score: 14.526497953163249
Financial ratios for COO — annual report dated 2025-10-31
Total revenue: 4092400000
Gross profit: 2682100000
Operating income: 682900000
Net income: 374900000
Capital expenditures: 362400000
Operating cash flow: 796100000
Depreciation & amortization: 377400000
Net tangible assets: 2799200000
Owner earnings: 389900000
Return on net tangible assets (%): 13.92897970848814
Capex to operating income (%): 53.067799092107194
Buffett classification: The Good
Stock price: 69.91
P/E ratio: 36.36860854441184
Shares outstanding: 195030630
Book value: 8239100000
P/B ratio: 1.6548641651758078
Market cap (USD): 13634591343.3
Debt to equity: 0.3040744741537304
Current ratio: 1.892882818116463
Quick ratio: 1.1326383896477354
Effective tax rate (%): 33.82171226831421
Interest coverage ratio: 6.829
COGS to revenue (%): 34.46144071938227
R&D to revenue (%): 4.207799824064119
SG&A to revenue (%): 39.7761704623204
Free cash flow (dilution-adjusted): 363200000
Buyback yield (%): 2.12767653019945
Retained earnings: 7643300000
Inventory turnover: 1.6670212765957446
Receivables turnover: 4.936550060313631
Capitalized R&D asset: 321459000
ROCI (R&D-adjusted, %): 6.034407498660529
Rosenberg metric: 0.5570599613152805
FCF margin (%): 8.874987782230475
Revenue growth (%): 5.057247009293012
Rule of 40 score: 13.932234791523488
Financial ratios for COO — quarterly report dated 2026-01-31
Total revenue: 1024100000
Gross profit: 695200000
Operating income: 212800000
Net income: 130800000
Capital expenditures: 102200000
Operating cash flow: 260900000
Depreciation & amortization: 95500000
Net tangible assets: 2916800000
Owner earnings: 124100000
Return on net tangible assets (%): 4.254662643993417
Capex to operating income (%): 48.026315789473685
Buffett classification: The Good
Stock price: 81.38
P/E ratio: 39.540589609865464
Shares outstanding: 195030630
Book value: 8364000000
P/B ratio: 1.8976079231707315
Market cap (USD): 15871592669.4
Debt to equity: 0.2988641798182688
Current ratio: 1.337218775459046
Quick ratio: 0.7879927304631197
Effective tax rate (%): 31.94588969823101
Interest coverage ratio: 9.5
COGS to revenue (%): 32.11600429645542
R&D to revenue (%): 4.3257494385313935
SG&A to revenue (%): 38.101747876183964
Free cash flow (dilution-adjusted): 158700000
Buyback yield (%): 0.5828022551154396
Retained earnings: 7774100000
Inventory turnover: 0.3752852578731173
Receivables turnover: 1.2688638334778837
Capitalized R&D asset: 86756000
ROCI (R&D-adjusted, %): 1.9575048598646394
Rosenberg metric: 1.0724637681159421
FCF margin (%): 15.496533541646324
Revenue growth (%): -3.849403811848653
Rule of 40 score: 11.64712972979767
Financial ratios for CSG.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007874015748031496
Shares outstanding: 103472512
Market cap (USD): 814744.188976378
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSG.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -94736.76470588235
Net income: -94736.76470588235
Capital expenditures: 0
Operating cash flow: -82585.29411764705
Net tangible assets: -198892.64705882352
Owner earnings: -94736.76470588235
Buffett classification: The Gruesome
Stock price: 0.029411764705882353
Shares outstanding: 103472512
Book value: -198892.64705882352
Market cap (USD): 3043309.176470588
Debt to equity: -0.49059868241070037
Current ratio: 0.035190469396490225
Quick ratio: 0.035190469396490225
Free cash flow (dilution-adjusted): -82585.29411764705
Buyback yield (%): 0
Retained earnings: -10975766.911764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSG.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -290022.72727272724
Net income: -290022.72727272724
Capital expenditures: 0
Operating cash flow: 237597.72727272726
Net tangible assets: -97450
Owner earnings: -290022.72727272724
Buffett classification: The Gruesome
Stock price: 0.03787878787878788
Shares outstanding: 103472512
Book value: -97450.00000000003
Market cap (USD): 3919413.3333333335
Debt to equity: -1.0596887292628694
Current ratio: 0.6339718636891346
Quick ratio: 0.6339718636891346
Free cash flow (dilution-adjusted): 237597.72727272726
Buyback yield (%): 0
Retained earnings: -11598388.636363637
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSG.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.04444444444444444
Shares outstanding: 103472512
Market cap (USD): 4598778.31111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSG.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -127913.98601398602
Net income: -100213.98601398602
Capital expenditures: 0
Operating cash flow: -155951.74825174827
Net tangible assets: -65914.68531468532
Owner earnings: -100213.98601398602
Buffett classification: The Gruesome
Stock price: 0.05594405594405595
Shares outstanding: 103472512
Book value: -65914.68531468531
Market cap (USD): 5788672.000000001
Debt to equity: -0.9788559061299837
Current ratio: 1.638437415846487
Quick ratio: 1.638437415846487
Free cash flow (dilution-adjusted): -155951.74825174827
Buyback yield (%): 0
Retained earnings: -10900478.321678322
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -248.883597523641
Rule of 40 score: 0
Financial ratios for CSG.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -221973.42657342658
Net income: -194273.42657342658
Capital expenditures: 0
Operating cash flow: -242730.76923076925
Net tangible assets: -65914.68531468532
Owner earnings: -194273.42657342658
Buffett classification: The Gruesome
Stock price: 0.05594405594405595
Shares outstanding: 103472512
Book value: -65914.68531468531
Market cap (USD): 5788672.000000001
Debt to equity: -0.9788559061299837
Current ratio: 1.638437415846487
Quick ratio: 1.638437415846487
Interest coverage ratio: -29.450918537762107
Free cash flow (dilution-adjusted): -242730.76923076925
Buyback yield (%): 0
Retained earnings: -10900478.321678322
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -431.8960473501597
Rule of 40 score: 0
Financial ratios for CSG.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -59012.58741258742
Net income: -64778.32167832168
Capital expenditures: 0
Operating cash flow: -42222.37762237762
Net tangible assets: -80546.85314685314
Owner earnings: -64778.32167832168
Buffett classification: The Gruesome
Stock price: 0.05594405594405595
Shares outstanding: 103472512
Book value: -80546.85314685316
Market cap (USD): 5788672.000000001
Debt to equity: -0.8439513118369188
Current ratio: 1.1538696004738873
Quick ratio: 1.1538696004738873
Interest coverage ratio: -10.235051546391754
Free cash flow (dilution-adjusted): -42222.37762237762
Buyback yield (%): 0
Retained earnings: -10965255.944055945
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -315.41020370024296
Rule of 40 score: 0
Financial ratios for CSG.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -48729.19708029197
Net income: -55204.37956204379
Capital expenditures: 0
Operating cash flow: -48378.83211678832
Net tangible assets: -27655.474452554743
Owner earnings: -55204.37956204379
Buffett classification: The Gruesome
Stock price: 0.0875912408759124
Shares outstanding: 103472512
Book value: -27655.474452554743
Market cap (USD): 9063285.722627737
Debt to equity: -2.5426784206081083
Current ratio: 1.6190559677857208
Quick ratio: 1.6190559677857208
Interest coverage ratio: -7.524684400360686
Free cash flow (dilution-adjusted): -48378.83211678832
Buyback yield (%): 0
Retained earnings: -11500691.240875911
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -60.98995971094199
Rule of 40 score: 0
Financial ratios for CSG.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -264191.3669064748
Net income: -283245.3237410072
Capital expenditures: 0
Operating cash flow: -129202.87769784173
Net tangible assets: -160157.55395683454
Owner earnings: -283245.3237410072
Buffett classification: The Gruesome
Stock price: 0.06474820143884892
Shares outstanding: 103472512
Book value: -160157.55395683454
Market cap (USD): 6699659.050359712
Debt to equity: -0.4697397796234823
Current ratio: 0.8096781907055115
Quick ratio: 0.8096781907055115
Interest coverage ratio: -13.864909763648718
Free cash flow (dilution-adjusted): -129202.87769784173
Buyback yield (%): 0
Retained earnings: -11497406.474820144
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSG.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -260392.700729927
Net income: -265757.6642335766
Capital expenditures: 0
Operating cash flow: -120054.74452554743
Net tangible assets: -264172.9927007299
Owner earnings: -265757.6642335766
Buffett classification: The Gruesome
Stock price: 0.058394160583941604
Shares outstanding: 103472512
Book value: -264172.9927007299
Market cap (USD): 6042190.481751825
Debt to equity: -0.30380998958324695
Current ratio: 0.203670263616653
Quick ratio: 0.203670263616653
Interest coverage ratio: -13.812064426204119
Free cash flow (dilution-adjusted): -120054.74452554743
Buyback yield (%): 0
Retained earnings: -11808190.510948904
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CSG.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -418115.32846715325
Net income: -430318.9781021897
Capital expenditures: 0
Operating cash flow: -343594.8905109489
Net tangible assets: -264172.9927007299
Owner earnings: -430318.9781021897
Buffett classification: The Gruesome
Stock price: 0.058394160583941604
Shares outstanding: 103472512
Book value: -264172.9927007299
Market cap (USD): 6042190.481751825
Debt to equity: -0.30380998958324695
Current ratio: 0.203670263616653
Quick ratio: 0.203670263616653
Interest coverage ratio: -16.274625678324856
Free cash flow (dilution-adjusted): -343594.8905109489
Buyback yield (%): 0
Retained earnings: -11808190.510948904
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTT.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.9849624060150375
Shares outstanding: 381238220
Market cap (USD): 756743534.4360902
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTT.AX — annual report dated 2022-06-30
Total revenue: 144747486.20689654
Gross profit: 25764656.55172414
Operating income: -18100802.068965517
Net income: -13146444.137931034
Capital expenditures: 5775984.827586208
Depreciation & amortization: 1225862.0689655172
Net tangible assets: 3528520.6896551726
Owner earnings: -17696566.896551725
Return on net tangible assets (%): -501.52935048486665
Buffett classification: The Gruesome
Stock price: 0.2620689655172414
Shares outstanding: 381238220
Book value: 11854231.724137928
P/B ratio: 8.42827340110059
Market cap (USD): 99910705.93103449
Debt to equity: 0
Current ratio: 0.9055151506479954
Quick ratio: 0.8805967285894952
COGS to revenue (%): 82.20027357511611
SG&A to revenue (%): 22.563320080050943
Free cash flow (dilution-adjusted): -15896032.413793104
Buyback yield (%): 0
Retained earnings: -14548165.51724138
Inventory turnover: 202.1701157533813
Receivables turnover: 38.55389455516147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -130.5521851587172
FCF margin (%): -10.981905683026454
Rule of 40 score: -10.981905683026454
Financial ratios for CTT.AX — annual report dated 2023-06-30
Total revenue: 275647033.77483445
Gross profit: 63327012.58278146
Operating income: 16207881.456953643
Net income: 10573201.986754967
Capital expenditures: 7991053.642384106
Depreciation & amortization: 2695124.5033112583
Net tangible assets: 8563123.178807948
Owner earnings: 5277272.847682118
Return on net tangible assets (%): 61.627898343706356
Capex to operating income (%): 49.30350498680207
Buffett classification: The Good
Stock price: 2.0596026490066226
P/E ratio: 74.26314647144615
Shares outstanding: 381238220
Book value: 21853940.397350997
P/B ratio: 35.929412890214834
Market cap (USD): 785199247.8145696
Debt to equity: 0
Current ratio: 1.1404003678236905
Quick ratio: 1.0955894417271739
Effective tax rate (%): 27.422009800632463
COGS to revenue (%): 77.02604968551525
SG&A to revenue (%): 10.425490131742311
Free cash flow (dilution-adjusted): 16148325.165562915
Buyback yield (%): 0.11408940362158933
Retained earnings: -3396890.728476821
Inventory turnover: 112.14047709240793
Receivables turnover: 18.816804576029355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 66.19774200790351
FCF margin (%): 5.858334459261356
Revenue growth (%): 90.43303686865765
Rule of 40 score: 96.29137132791901
Financial ratios for CTT.AX — annual report dated 2024-06-30
Total revenue: 494836755.3333333
Gross profit: 103335913.33333333
Operating income: 12437804.666666666
Net income: 6983004.666666667
Capital expenditures: 9520975.333333334
Depreciation & amortization: 4328309.333333333
Net tangible assets: 5475942
Owner earnings: 1790338.666666666
Return on net tangible assets (%): 32.69462435260757
Capex to operating income (%): 76.54868032177383
Buffett classification: The Gruesome
Stock price: 0.7799999999999999
P/E ratio: 42.58422066069552
Shares outstanding: 381238220
Book value: 24048030.66666667
P/B ratio: 12.36549535892696
Market cap (USD): 297365811.59999996
Debt to equity: 0
Current ratio: 1.0816174314853892
Quick ratio: 1.0527479615817605
Effective tax rate (%): 47.323187930442614
COGS to revenue (%): 79.11717102264889
SG&A to revenue (%): 11.972005992176816
Free cash flow (dilution-adjusted): 32451841.333333332
Buyback yield (%): 2.3072062755806955
Retained earnings: 3563468
Inventory turnover: 201.96925637298045
Receivables turnover: 29.60764853712502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 47.10577825815413
FCF margin (%): 6.558090316365653
Revenue growth (%): 79.51825875171455
Rule of 40 score: 86.0763490680802
Financial ratios for CU.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.055118110236222
Shares outstanding: 205716737
Market cap (USD): 4742823668.787402
Buyback yield (%): 1.9424290398618669
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CU.TO — annual report dated 2022-12-31
Total revenue: 2976470588.235294
Gross profit: 2010294117.6470587
Operating income: 1211764705.8823528
Net income: 469852941.1764706
Capital expenditures: 899264705.8823528
Operating cash flow: 1573529411.7647057
Depreciation & amortization: 472058823.52941173
Net tangible assets: 4455882352.941176
Owner earnings: 42647058.82352948
Return on net tangible assets (%): 0.9570957095709588
Capex to operating income (%): 74.21116504854369
Buffett classification: The Good
Stock price: 22.551470588235293
P/E ratio: 9.873759505148671
Shares outstanding: 205716737
Book value: 5195588235.294117
P/B ratio: 0.8929142830158506
Market cap (USD): 4639214943.963235
Debt to equity: 1.3573450325502407
Current ratio: 1.4176157934700075
Quick ratio: 1.3993925588458618
Effective tax rate (%): 23.74701670644391
Interest coverage ratio: 4.089330024813896
COGS to revenue (%): 32.4604743083004
SG&A to revenue (%): 9.23913043478261
Free cash flow (dilution-adjusted): 566911764.7058823
Buyback yield (%): 0
Retained earnings: 2894117647.058823
Inventory turnover: 54.75
Receivables turnover: 4.433734939759036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.977925158541897
FCF margin (%): 19.046442687747035
Rule of 40 score: 19.046442687747035
Financial ratios for CU.TO — annual report dated 2023-12-31
Total revenue: 2875757575.7575755
Gross profit: 1947727272.7272727
Operating income: 1045454545.4545454
Net income: 543181818.1818181
Capital expenditures: 906818181.8181818
Operating cash flow: 1348484848.4848485
Depreciation & amortization: 549242424.2424242
Net tangible assets: 4414393939.393939
Owner earnings: 185606060.60606074
Return on net tangible assets (%): 4.204564956238205
Capex to operating income (%): 86.73913043478261
Buffett classification: The Gruesome
Stock price: 21.318181818181817
P/E ratio: 8.073736372635983
Shares outstanding: 205716737
Book value: 5421212121.21212
P/B ratio: 0.8089531832280604
Market cap (USD): 4385506802.409091
Debt to equity: 1.479737283398547
Current ratio: 1.010548523206751
Quick ratio: 0.9655414908579465
Effective tax rate (%): 21.639344262295086
Interest coverage ratio: 3.0463576158940393
COGS to revenue (%): 32.270811380400424
SG&A to revenue (%): 10.35300316122234
Free cash flow (dilution-adjusted): 334090909.09090906
Buyback yield (%): 0
Retained earnings: 3093939393.939394
Inventory turnover: 19.140625
Receivables turnover: 4.709677419354838
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.348914243651087
FCF margin (%): 11.61749209694415
Revenue growth (%): -3.3836387591328303
Rule of 40 score: 8.23385333781132
Financial ratios for CU.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 130370370.37037036
Buffett classification: The Gruesome
Stock price: 24.511111111111113
Shares outstanding: 205716737
Market cap (USD): 5042345798.0222225
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CU.TO — annual report dated 2024-12-31
Total revenue: 2616783216.783217
Gross profit: 1818881118.881119
Operating income: 953146853.1468532
Net income: 343356643.3566434
Capital expenditures: 1041258741.2587413
Operating cash flow: 1340559440.5594406
Depreciation & amortization: 497202797.20279723
Net tangible assets: 4037062937.0629373
Owner earnings: -200699300.69930065
Return on net tangible assets (%): -4.9714186731335515
Capex to operating income (%): 109.24431401320615
Buffett classification: The Gruesome
Stock price: 22.74825174825175
P/E ratio: 13.62925754503055
Shares outstanding: 205716737
Book value: 4979720279.72028
P/B ratio: 0.9397508010967562
Market cap (USD): 4679696122.104896
Debt to equity: 1.5605954219912934
Current ratio: 1.1006768189509306
Quick ratio: 1.0507614213197969
Effective tax rate (%): 21.314102564102562
Interest coverage ratio: 2.6936758893280635
COGS to revenue (%): 30.491715660074824
SG&A to revenue (%): 11.998931052912882
Free cash flow (dilution-adjusted): 225174825.1748252
Buyback yield (%): 0
Retained earnings: 2796503496.5034966
Inventory turnover: 19.338983050847457
Receivables turnover: 4.541262135922331
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.029639460296394
FCF margin (%): 8.60502405130946
Revenue growth (%): -9.005430817864946
Rule of 40 score: -0.400406766555486
Financial ratios for CU.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 126573426.57342657
Buffett classification: The Gruesome
Stock price: 22.74825174825175
Shares outstanding: 205716737
Market cap (USD): 4679696122.104896
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CU.TO — quarterly report dated 2025-03-31
Total revenue: 758741258.7412587
Gross profit: 540559440.5594406
Operating income: 274825174.8251748
Net income: 167132867.13286713
Capital expenditures: 262937062.93706295
Operating cash flow: 445454545.4545455
Depreciation & amortization: 126573426.57342657
Net tangible assets: 4098601398.601399
Owner earnings: 30769230.769230753
Return on net tangible assets (%): 0.7507251322299944
Capex to operating income (%): 95.67430025445293
Buffett classification: The Gruesome
Stock price: 24.482517482517483
P/E ratio: 7.533622345575314
Shares outstanding: 205716737
Book value: 5044055944.055944
P/B ratio: 0.9984947958366837
Market cap (USD): 5036463610.048951
Debt to equity: 1.568140856786358
Current ratio: 1.0367316341829087
Quick ratio: 0.9880059970014993
Effective tax rate (%): 22.14983713355049
Interest coverage ratio: 3.1439999999999997
COGS to revenue (%): 28.755760368663598
SG&A to revenue (%): 10.046082949308756
Free cash flow (dilution-adjusted): 168531468.53146854
Buyback yield (%): 0
Retained earnings: 2855244755.2447553
Inventory turnover: 4.8
Receivables turnover: 1.7249602543720188
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7248946629213482
FCF margin (%): 22.211981566820278
Rule of 40 score: 22.211981566820278
Financial ratios for CU.TO — quarterly report dated 2025-06-30
Total revenue: 614598540.1459854
Gross profit: 429197080.2919708
Operating income: 169343065.69343063
Net income: 83211678.83211678
Capital expenditures: 244525547.44525546
Operating cash flow: 321897810.21897805
Depreciation & amortization: 132846715.32846715
Net tangible assets: 4245985401.4598536
Owner earnings: -28467153.284671545
Return on net tangible assets (%): -0.6704486848891185
Capex to operating income (%): 144.39655172413794
Buffett classification: The Gruesome
Stock price: 26.33576642335766
P/E ratio: 21.641006454221223
Shares outstanding: 205716737
Book value: 5244525547.445255
P/B ratio: 1.0330215547613082
Market cap (USD): 5417707935.007298
Debt to equity: 1.5807933194154487
Current ratio: 1.1961492178098678
Quick ratio: 1.1167268351383877
Effective tax rate (%): 19.148936170212767
Interest coverage ratio: 1.886178861788618
COGS to revenue (%): 30.16627078384798
SG&A to revenue (%): 11.045130641330166
Free cash flow (dilution-adjusted): 48905109.48905109
Buyback yield (%): 0
Retained earnings: 2981751824.817518
Inventory turnover: 3.848484848484848
Receivables turnover: 2.0790123456790126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0066386080617866
FCF margin (%): 7.957244655581948
Revenue growth (%): -18.997611759561376
Rule of 40 score: -11.040367103979428
Financial ratios for CU.TO — quarterly report dated 2025-09-30
Total revenue: 569784172.6618706
Gross profit: 405755395.68345326
Operating income: 161870503.5971223
Net income: 73381294.96402878
Capital expenditures: 255395683.4532374
Operating cash flow: 336690647.4820144
Depreciation & amortization: 131654676.25899282
Net tangible assets: 4149640287.7697845
Owner earnings: -50359712.23021582
Return on net tangible assets (%): -1.2135922330097084
Capex to operating income (%): 157.77777777777777
Buffett classification: The Gruesome
Stock price: 27.14388489208633
P/E ratio: 17.249013589644388
Shares outstanding: 205716737
Book value: 5156115107.91367
P/B ratio: 1.0829764876531323
Market cap (USD): 5583951429.503597
Debt to equity: 1.683549602344077
Current ratio: 1.5568065506653022
Quick ratio: 1.4759467758444218
Effective tax rate (%): 22.72727272727273
Interest coverage ratio: 1.8292682926829267
COGS to revenue (%): 28.787878787878785
SG&A to revenue (%): 12.373737373737372
Free cash flow (dilution-adjusted): 54676258.99280576
Buyback yield (%): 0
Retained earnings: 2905755395.6834536
Inventory turnover: 2.8860759493670884
Receivables turnover: 1.9459459459459463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9497277447131821
FCF margin (%): 9.595959595959593
Revenue growth (%): -7.291648866180194
Rule of 40 score: 2.3043107297793997
Financial ratios for CU.TO — annual report dated 2025-12-31
Total revenue: 2693430656.934306
Gross profit: 1897080291.9708028
Operating income: 608759124.0875912
Net income: 94890510.9489051
Capital expenditures: 1045255474.4525547
Operating cash flow: 1504379562.0437956
Depreciation & amortization: 943795620.4379561
Net tangible assets: 3904379562.043795
Owner earnings: -6569343.065693498
Return on net tangible assets (%): -0.16825574873808363
Capex to operating income (%): 171.70263788968828
Buffett classification: The Gruesome
Stock price: 30.576642335766422
P/E ratio: 66.28826240715385
Shares outstanding: 205716737
Book value: 4816058394.160585
P/B ratio: 1.306073675800242
Market cap (USD): 6290127089.729927
Debt to equity: 1.8764777205213696
Current ratio: 1.5575304022450889
Quick ratio: 1.5163704396632367
Effective tax rate (%): 35.64356435643564
Interest coverage ratio: 1.6449704142011834
COGS to revenue (%): 29.56639566395664
SG&A to revenue (%): 10.623306233062332
Free cash flow (dilution-adjusted): 360583941.6058394
Buyback yield (%): 2.9010821120412777
Retained earnings: 2587591240.875912
Inventory turnover: 24.795454545454543
Receivables turnover: 5.607902735562309
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.55392679081263
FCF margin (%): 13.387533875338754
Revenue growth (%): 2.9290710693762034
Rule of 40 score: 16.316604944714957
Financial ratios for CU.TO — quarterly report dated 2025-12-31
Total revenue: 708759124.0875912
Gross profit: 491970802.919708
Operating income: -11678832.11678832
Net income: -237226277.37226275
Capital expenditures: 267153284.67153284
Operating cash flow: 375912408.75912404
Depreciation & amortization: 545255474.4525547
Net tangible assets: 3904379562.043795
Owner earnings: 40875912.40875915
Buffett classification: The Gruesome
Stock price: 30.576642335766422
P/E ratio: 72.71859915921024
Shares outstanding: 205716737
Book value: 4816058394.160585
P/B ratio: 1.306073675800242
Market cap (USD): 6290127089.729927
Debt to equity: 1.8764777205213696
Current ratio: 1.5575304022450889
Quick ratio: 1.5163704396632367
Interest coverage ratio: -0.11764705882352941
COGS to revenue (%): 30.587023686920702
SG&A to revenue (%): 9.474768280123584
Free cash flow (dilution-adjusted): 80291970.8029197
Buyback yield (%): 0
Retained earnings: 2587591240.875912
Inventory turnover: 6.749999999999999
Receivables turnover: 1.4756838905775076
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.06818084970383943
FCF margin (%): 11.328527291452112
Revenue growth (%): 24.390805868908025
Rule of 40 score: 35.71933316036014
Financial ratios for CV — quarterly report dated 2025-09-30
Total revenue: 3538000
Gross profit: 1914000
Operating income: -8019000
Net income: -7921000
Capital expenditures: 12000
Operating cash flow: -5666000
Depreciation & amortization: 143000
Net tangible assets: 20442000
Owner earnings: -7790000
Return on net tangible assets (%): -38.10781723901771
Buffett classification: The Gruesome
Stock price: 4.84
Shares outstanding: 49963586
Book value: 20442000
P/B ratio: 11.829750329713336
Market cap (USD): 241823756.23999998
Debt to equity: 0.0478426768417963
Current ratio: 5.1877022653721685
Quick ratio: 4.500107874865156
COGS to revenue (%): 45.90163934426229
R&D to revenue (%): 172.1311475409836
SG&A to revenue (%): 108.62068965517241
Free cash flow (dilution-adjusted): -5985000
Buyback yield (%): 0
Retained earnings: -148271000
Inventory turnover: 0.509570128647631
Receivables turnover: 1.8919786096256686
Capitalized R&D asset: 9387950
ROCI (R&D-adjusted, %): -20.139880986630583
Rosenberg metric: 0.03036556603773585
FCF margin (%): -169.16336913510457
Revenue growth (%): 6.726998491704374
Rule of 40 score: -162.4363706434002
Financial ratios for CV — annual report dated 2025-12-31
Total revenue: 13554000
Gross profit: 7173000
Operating income: -25516000
Net income: -25315000
Capital expenditures: 90000
Operating cash flow: -22864000
Depreciation & amortization: 567000
Net tangible assets: 13260000
Owner earnings: -24838000
Return on net tangible assets (%): -187.31523378582202
Buffett classification: The Gruesome
Stock price: 10.69
Shares outstanding: 49963586
Book value: 13260000
P/B ratio: 40.27984421870286
Market cap (USD): 534110734.34
Debt to equity: 0.06689291101055807
Current ratio: 3.7653038174836233
Quick ratio: 3.0905805285746557
COGS to revenue (%): 47.07835325365206
R&D to revenue (%): 135.08927253947175
SG&A to revenue (%): 106.08676405489155
Free cash flow (dilution-adjusted): -23780000
Buyback yield (%): 0
Retained earnings: -155665000
Inventory turnover: 2.1362571141613658
Receivables turnover: 5.425940752602082
Capitalized R&D asset: 31520290
ROCI (R&D-adjusted, %): -47.418511654881094
Rosenberg metric: 0.05264550264550265
FCF margin (%): -175.44636269735872
Revenue growth (%): 15.294317795168425
Rule of 40 score: -160.1520449021903
Financial ratios for CV — quarterly report dated 2025-12-31
Total revenue: 3918000
Gross profit: 1954000
Operating income: -7464000
Net income: -7394000
Capital expenditures: 8000
Operating cash flow: -7686000
Depreciation & amortization: 146000
Net tangible assets: 13260000
Owner earnings: -7256000
Return on net tangible assets (%): -54.72096530920061
Buffett classification: The Gruesome
Stock price: 10.69
Shares outstanding: 49963586
Book value: 13260000
P/B ratio: 40.27984421870286
Market cap (USD): 534110734.34
Debt to equity: 0.06689291101055807
Current ratio: 3.7653038174836233
Quick ratio: 3.0905805285746557
COGS to revenue (%): 50.12761613067892
R&D to revenue (%): 146.01837672281778
SG&A to revenue (%): 94.35936702399184
Free cash flow (dilution-adjusted): -7891000
Buyback yield (%): 0
Retained earnings: -155665000
Inventory turnover: 0.6575159022430532
Receivables turnover: 1.5684547638110489
Capitalized R&D asset: 10920660
ROCI (R&D-adjusted, %): -27.62089617046657
Rosenberg metric: 0.006568144499178982
FCF margin (%): -201.40377743746808
Revenue growth (%): 10.740531373657433
Rule of 40 score: -190.66324606381065
Financial ratios for DAIO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.61
Shares outstanding: 10264262
Market cap (USD): 47318247.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DAIO — annual report dated 2022-12-31
Total revenue: 24217000
Gross profit: 13210000
Operating income: -749000
Net income: -1120000
Capital expenditures: 1080000
Operating cash flow: -1052000
Depreciation & amortization: 560000
Net tangible assets: 19109000
Owner earnings: -1640000
Return on net tangible assets (%): -8.58234339839866
Buffett classification: The Gruesome
Stock price: 3.97
Shares outstanding: 10264262
Book value: 19109000
P/B ratio: 2.1324569647809932
Market cap (USD): 40749120.14
Debt to equity: 0.12030980166413732
Current ratio: 3.781927520177243
Quick ratio: 2.7135622725114734
COGS to revenue (%): 45.45154230499236
R&D to revenue (%): 25.118718255770737
SG&A to revenue (%): 32.52260808522938
Free cash flow (dilution-adjusted): -3308000
Buyback yield (%): 0.40491671828279135
Retained earnings: -3131000
Inventory turnover: 1.630425122204118
Receivables turnover: 4.851161858974359
Capitalized R&D asset: 6083000
ROCI (R&D-adjusted, %): 12.277965514253529
FCF margin (%): -13.65982574224718
Rule of 40 score: -13.65982574224718